DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 37 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 470,000 | $1,212,600 | 3.97% |
Altium Capital Management LP | 496,000 | $1,279,680 | 0.67% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 168,730 | $435,323 | 0.61% |
Bleichroeder LP | 222,317 | $573,578 | 0.14% |
Aristides Capital LLC | 106,333 | $274,339 | 0.12% |
COOPERMAN LEON G | 875,993 | $2,260,062 | 0.12% |
EAM Investors, LLC | 212,512 | $548,281 | 0.11% |
CATALYST FINANCIAL PARTNERS LLC | 36,267 | $93,569 | 0.03% |
Stonebridge Capital Advisors LLC | 20,000 | $51,600 | 0.01% |
Legend Financial Advisors, Inc. | 1,000 | $2,580 | 0.00% |